(Q43190467)

English

Interferon beta in multiple sclerosis

scientific article published in November 1996

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

15 November 2017

0 references

Interferon beta in multiple sclerosis. (English)

1 reference

stated in

Europe PubMed Central

15 November 2017

Richards RG

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2352529

retrieved

15 November 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

stated in

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

313

1 reference

stated in

Europe PubMed Central

15 November 2017

7066

1 reference

stated in

Europe PubMed Central

15 November 2017

1159

1 reference

stated in

Europe PubMed Central

15 November 2017

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352529

retrieved

25 May 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352529

retrieved

25 May 2018

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352529

retrieved

25 May 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2352529

retrieved

25 May 2018

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8916730

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BMJ.313.7066.1159

1 reference

stated in

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

PMC publication ID

2352529

retrieved

15 November 2017

PubMed publication ID

8916730

1 reference

stated in

Europe PubMed Central

PMC publication ID

2352529

retrieved

15 November 2017

ResearchGate publication ID

14289844

0 references

(Q43190467)

Interferon beta in multiple sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)